טוען...
A novel model for Ki67 assessment in breast cancer
ABSTRACT: BACKGROUND: Ki67 is currently the proliferation biomarker of choice, with both prognostic and predictive value in breast cancer. A lack of consensus regarding Ki67 use in pre-analytical, analytical and post-analytical practice may hinder its formal acceptance in the clinical setting. METHO...
שמור ב:
Main Authors: | , , , , |
---|---|
פורמט: | Artigo |
שפה: | Inglês |
יצא לאור: |
BioMed Central
2014
|
נושאים: | |
גישה מקוונת: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4069280/ https://ncbi.nlm.nih.gov/pubmed/24934660 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1746-1596-9-118 |
תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|